Search Results
1
Study Matches
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa: Phase 2 Double-Blind, 12 week placebo controlled period followed by 24 week active treatment period. Oral Medication, Males/Females 18 years and older with Hidradenitis Suppurativa.
Hidradenitis Suppurativa (HS) is a chronic recurrent and debilitating skin condition that typically presents with deep and painful lesions. The most common areas affected are the armpits, the groin, and the anus and genitals area.
The purpose of this study is to see if Avacopan is safe and effective for the treatment of HS.
Samantha Gettle at sgettle2@pennstatehealth.psu.edu or 717-531-5136
All
18 year(s) or older
NCT03852472
Skin Conditions